(NASDAQ: OPK) Opko Health's forecast annual revenue growth rate of -23.65% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.15%.
Opko Health's revenue in 2026 is $501,640,000.On average, 7 Wall Street analysts forecast OPK's revenue for 2026 to be $343,394,395,483, with the lowest OPK revenue forecast at $304,888,009,586, and the highest OPK revenue forecast at $445,793,463,726. On average, 7 Wall Street analysts forecast OPK's revenue for 2027 to be $200,402,498,142, with the lowest OPK revenue forecast at $181,186,430,518, and the highest OPK revenue forecast at $215,958,008,835.
In 2028, OPK is forecast to generate $203,721,502,094 in revenue, with the lowest revenue forecast at $187,007,681,297 and the highest revenue forecast at $223,212,297,116.